Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Ontology highlight
ABSTRACT: Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
PROVIDER: PRJNA681790 | ENA |
REPOSITORIES: ENA
ACCESS DATA